FUNDING FOR CETUXIMAB

That this House notes the case of Mr Terence Booth, who is suffering from metastatic colorectal cancer; recognises that Cetuximab, the only drug which can help prolong his life, is not available on the NHS, with treatment costing in the region of £20,000; further notes that his application for funding from the primary care trust has been turned down on two occasions; and calls on the Government to improve access to life-prolonging drugs by making them available on the NHS so that all sufferers from metastatic colorectal cancer and other illnesses are not denied access to drugs which can prolong life.